ARMP RSI Chart
Last 7 days
-5.4%
Last 30 days
-28.5%
Last 90 days
-33.6%
Trailing 12 Months
69.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 5.1M | 4.2M | 4.1M | 4.5M |
2022 | 4.6M | 5.4M | 5.4M | 5.5M |
2021 | 1.7M | 2.6M | 3.6M | 4.5M |
2020 | 0 | 351.0K | 587.0K | 823.0K |
2017 | 183.0K | 108.0K | 117.0K | 115.0K |
2016 | 479.0K | 480.0K | 366.0K | 260.0K |
2015 | 407.0K | 408.0K | 448.0K | 475.0K |
2014 | 163.0K | 245.0K | 327.0K | 409.0K |
2013 | 0 | 0 | 0 | 81.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 14, 2024 | birx deborah | acquired | - | - | 60,000 | chief executive officer |
Mar 14, 2024 | rychlik richard | acquired | - | - | 10,000 | corporate controller and pfo |
Dec 21, 2023 | birx deborah | acquired | - | - | 200,000 | chief executive officer |
Mar 31, 2022 | innoviva, inc. | bought | 26,926,000 | 5.00 | 5,385,210 | - |
Feb 09, 2022 | innoviva, inc. | bought | 18,074,000 | 5.00 | 3,614,790 | - |
Oct 29, 2021 | innoviva, inc. | bought | 4,000,000 | 3.3 | 1,212,120 | - |
Mar 17, 2021 | innoviva, inc. | bought | 13,929,300 | 3.25 | 4,285,940 | - |
Jan 26, 2021 | innoviva, inc. | bought | 6,070,710 | 3.25 | 1,867,910 | - |
Mar 27, 2020 | innoviva, inc. | bought | 22,149,700 | 2.87 | 7,717,660 | - |
Which funds bought or sold ARMP recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 01, 2024 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | sold off | - | - | - | -% |
Apr 23, 2024 | Tennessee Valley Asset Management Partners | sold off | -100 | -904 | - | -% |
Apr 18, 2024 | SeaCrest Wealth Management, LLC | added | 80.79 | 80,624 | 137,008 | 0.02% |
Apr 16, 2024 | Trifecta Capital Advisors, LLC | unchanged | - | 671 | 2,985 | -% |
Apr 11, 2024 | SALEM INVESTMENT COUNSELORS INC | unchanged | - | 94.00 | 418 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 59.48 | 197,145 | 470,052 | -% |
Feb 14, 2024 | Royal Bank of Canada | added | 1,466 | 1,000 | 1,000 | -% |
Feb 14, 2024 | STATE STREET CORP | unchanged | - | 9,672 | 130,572 | -% |
Feb 14, 2024 | BANK OF AMERICA CORP /DE/ | added | - | 152,290 | 2,055,620 | -% |
Feb 14, 2024 | Team Financial Group, LLC | unchanged | - | 17.00 | 230 | -% |
Unveiling Armata Pharmaceuticals Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Armata Pharmaceuticals Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 47.9B | 6.8B | -8.03 | 7 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.3B | 2.0B | -58.02 | 9.62 | ||||
BMRN | 15.7B | 2.5B | 76.24 | 6.34 | ||||
INCY | 12.1B | 3.8B | 16.19 | 3.2 | ||||
MID-CAP | ||||||||
APLS | 5.7B | 396.6M | -10.82 | 14.42 | ||||
BBIO | 5.2B | 107.9M | -9.53 | 48.09 | ||||
AXSM | 3.5B | 270.6M | -14.81 | 13.09 | ||||
ARWR | 3.0B | 240.7M | -10.2 | 12.18 | ||||
ACAD | 2.8B | 726.4M | -45.79 | 3.86 | ||||
SMALL-CAP | ||||||||
CPRX | 1.7B | 398.2M | 24.31 | 4.36 | ||||
NVAX | 687.2M | 983.7M | -1.26 | 0.7 | ||||
CRBP | 408.0M | 881.7K | -9.15 | 466.16 | ||||
INO | 282.8M | 4.9M | -2.09 | 58.11 | ||||
IBIO | 6.9M | 2.1M | -0.25 | 2.14 |
Armata Pharmaceuticals Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2017Q4 | 2017Q3 | 2017Q2 | 2017Q1 | 2016Q4 | 2016Q3 |
Revenue | 24.7% | 1,528,000 | 1,225,000 | 980,000 | 796,000 | 1,051,000 | 1,338,000 | 1,883,000 | 1,236,000 | 989,000 | 1,251,000 | 1,168,000 | 1,066,000 | 804,500 | 543,000 | 281,500 | 20,000 | 38,000 | 28,000 | 29,000 | 22,000 | 29,000 |
Operating Expenses | -3.9% | 11,107,000 | 11,561,000 | 10,609,000 | 12,142,000 | 11,379,000 | 9,961,000 | 11,103,000 | 10,011,000 | 7,037,000 | 7,394,000 | 7,364,000 | 6,501,000 | 6,957,000 | 5,911,000 | 4,621,000 | - | - | - | - | - | - |
S&GA Expenses | -11.3% | 3,178,500 | 3,583,000 | 2,350,000 | 2,538,000 | 1,810,000 | 1,561,000 | 2,083,000 | 1,983,000 | 2,223,000 | 1,768,000 | 2,139,000 | 2,151,000 | 1,977,000 | 1,845,000 | 1,973,000 | - | - | - | - | - | - |
R&D Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 92,000 | 292,000 | 138,000 | 10,958,000 | -829,000 | 1,130,000 | 1,490,000 | 802,000 | 1,655,000 |
EBITDA Margin | 119.8% | 0.78 | -3.93 | -3.83 | -3.14 | -2.90 | -2.76 | -2.81 | -3.26 | -3.83 | -3.80 | -5.01 | -8.04 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 23.3% | 1,450,000 | 1,176,000 | - | - | - | - | - | - | - | 2,000 | - | 62,000 | 177,000 | 150,000 | 142,000 | - | - | - | 7,000 | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1,302,000 | - | - | - |
Earnings Before Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2,352,000 | -779,000 | -7,763,000 | - | -10,056,000 | -2,375,000 |
EBT Margin | 99.6% | -0.02 | -4.16 | -4.04 | -3.32 | -3.06 | -2.93 | -3.00 | -3.51 | -4.14 | -4.14 | -5.51 | -8.92 | - | - | - | - | - | - | - | - | - |
Net Income | 36.3% | -19,847,000 | -31,161,000 | -3,547,000 | -14,490,000 | -10,314,000 | -8,614,000 | -9,215,000 | -8,774,000 | -6,047,000 | -5,419,000 | -6,194,000 | -5,495,000 | -6,624,000 | -5,769,000 | -4,710,000 | - | - | - | - | - | - |
Net Income Margin | -3.8% | -15.25 | -14.69 | -8.88 | -8.41 | -6.70 | -5.67 | -5.24 | -5.50 | -5.69 | -5.83 | -7.88 | -11.96 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 20.4% | -10,506,000 | -13,199,000 | -12,282,000 | -19,580,000 | -10,030,000 | -11,627,000 | -9,284,000 | -3,751,000 | -8,826,000 | -5,546,000 | -4,734,000 | -5,773,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -12.8% | 98.00 | 113 | 101 | 109 | 96.00 | 93.00 | 101 | 108 | 70.00 | 43.00 | 48.00 | 53.00 | 40.00 | 46.00 | 49.00 | 44.00 | 25.00 | 29.00 | 35.00 | 10.00 | 15.00 |
Current Assets | -47.7% | 19.00 | 37.00 | 27.00 | 39.00 | 27.00 | 33.00 | 41.00 | 49.00 | 15.00 | 14.00 | 20.00 | 24.00 | 11.00 | 17.00 | 21.00 | 26.00 | 7.00 | 10.00 | 14.00 | 6.00 | 10.00 |
Cash Equivalents | -43.6% | 14.00 | 24.00 | 12.00 | 25.00 | 15.00 | 25.00 | 37.00 | 46.00 | 11.00 | 12.00 | 18.00 | 22.00 | 11.00 | 16.00 | 20.00 | 24.00 | 7.00 | 9.00 | 13.00 | 6.00 | 10.00 |
Net PPE | 35.8% | 13.00 | 9.00 | 9.00 | 5.00 | 4.00 | 4.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 0.00 | 3.00 |
Goodwill | 0% | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | - | - |
Liabilities | 4.2% | 130 | 125 | 82.00 | 86.00 | 60.00 | 47.00 | 48.00 | 46.00 | 44.00 | 19.00 | 20.00 | 19.00 | 21.00 | 21.00 | 20.00 | 11.00 | 11.00 | 11.00 | 12.00 | 5.00 | 7.00 |
Current Liabilities | -24.8% | 16.00 | 22.00 | 52.00 | 51.00 | 25.00 | 7.00 | 7.00 | 6.00 | 5.00 | 5.00 | 6.00 | 5.00 | 7.00 | 7.00 | 5.00 | 6.00 | 5.00 | 5.00 | 6.00 | 4.00 | 2.00 |
Long Term Debt | 17.9% | 59.00 | 50.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | 17.9% | 59.00 | 50.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -Infinity% | -32.06 | - | 19.00 | 22.00 | 36.00 | 46.00 | 53.00 | 62.00 | 25.00 | 24.00 | 29.00 | 34.00 | 19.00 | 25.00 | 30.00 | 33.00 | 15.00 | 18.00 | 23.00 | 4.00 | 8.00 |
Retained Earnings | -6.9% | -308 | -289 | -257 | -254 | -239 | -229 | -220 | -211 | -202 | -196 | -191 | -185 | -179 | -173 | -167 | -162 | -157 | -152 | -145 | -409 | -138 |
Additional Paid-In Capital | 0.1% | 276 | 276 | 277 | 276 | 275 | 275 | 274 | 273 | 228 | 220 | 220 | 219 | 198 | 198 | 197 | 196 | 172 | 171 | 169 | 415 | 146 |
Accumulated Depreciation | - | 12.00 | - | - | - | 11.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding | 0.0% | 36.00 | 36.00 | 36.00 | 36.00 | 36.00 | 36.00 | 36.00 | 29.00 | 27.00 | 23.00 | 23.00 | 20.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 13.00 | - | - | - | 42.00 | - | - | - | 39.00 | - | - | - | 38.00 | - | - | - | 39.00 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 16.3% | -8,106 | -9,687 | -12,060 | -17,570 | -10,485 | -10,333 | -8,148 | -3,515 | -8,598 | -4,964 | -4,538 | -5,475 | -6,302 | -3,880 | -3,856 | -4,232 | -2,729 | -4,567 | -5,827 | -2,459 | -3,195 |
Share Based Compensation | 151.7% | 193 | -373 | 261 | 857 | 817 | 846 | 949 | 493 | 664 | 469 | 907 | 842 | 862 | 663 | 906 | 1,044 | 1,047 | 2,499 | 626 | 99.00 | -1.00 |
Cashflow From Investing | 31.9% | -2,390 | -3,512 | -222 | -2,010 | 455 | -1,294 | -1,136 | -236 | -228 | -582 | -196 | -298 | -366 | -81.00 | -273 | -104 | 72.00 | 65.00 | 2,882 | -142 | -535 |
Cashflow From Financing | -100.2% | -43.00 | 24,805 | -368 | 29,594 | -500 | 31.00 | -146 | 44,631 | 7,038 | 86.00 | -185 | 18,579 | 432 | 60.00 | 306 | 22,412 | - | - | 9,975 | -1,000 | 6,089 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Consolidated Statements of Operations | ||
Grant revenue | $ 4,529 | $ 5,508 |
Operating expenses | ||
Research and development | 33,770 | 35,017 |
General and administrative | 11,649 | 7,437 |
Total operating expenses | 45,419 | 42,454 |
Loss from operations | (40,890) | (36,946) |
Other income (expense) | ||
Interest income | 179 | 29 |
Interest expense | (2,626) | |
Change in fair value of convertible debt | (21,845) | |
Loss on convertible debt extinguishment | (3,863) | |
Total other (expense) income, net | (28,155) | 29 |
Net loss | $ (69,045) | $ (36,917) |
Per share information: | ||
Net loss per share, basic (in dollars per share) | $ (1.91) | $ (1.08) |
Net loss per share, diluted (in dollars per share) | $ (1.91) | $ (1.08) |
Weighted average shares outstanding, basic (in shares) | 36,075,555 | 34,294,124 |
Weighted average shares outstanding, diluted (in shares) | 36,075,555 | 34,294,124 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 13,523 | $ 14,852 |
Prepaid expenses and other current assets | 2,265 | 3,664 |
Other receivables | 3,363 | 8,531 |
Total current assets | 19,151 | 27,047 |
Restricted cash | 5,720 | 5,960 |
Property and equipment, net | 12,559 | 3,617 |
Operating lease right-of-use asset | 44,717 | 43,035 |
In-process research and development | 10,256 | 10,256 |
Goodwill | 3,490 | 3,490 |
Other assets | 2,470 | 2,429 |
Total assets | 98,363 | 95,834 |
Current liabilities | ||
Accounts payable and accrued liabilities | 5,689 | 6,034 |
Accrued compensation | 768 | 1,828 |
Current portion of operating lease liabilities | 9,481 | 17,011 |
Other current liabilities | 523 | |
Total current liabilities | 16,461 | 24,873 |
Operating lease liabilities, net of current portion | 28,583 | 31,804 |
Convertible debt | 58,633 | |
Long-term debt | 23,674 | |
Deferred tax liability | 3,077 | 3,077 |
Total liabilities | 130,428 | 59,754 |
Commitments and contingencies (Note 12) | ||
Shareholders' (deficit) equity | ||
Common stock, $0.01 par value; 217,000,000 shares authorized; 36,122,932 and 36,144,706 shares issued and outstanding at December 31, 2023 and 2022, respectively | 361 | 361 |
Additional paid-in capital | 276,393 | 275,493 |
Accumulated deficit | (308,819) | (239,774) |
Total shareholders' (deficit) equity | (32,065) | 36,080 |
Total liabilities and shareholders' (deficit) equity | $ 98,363 | $ 95,834 |